Vital Farms, Inc.
For the period ended Sep 28, 2025. Filed Nov 4, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 28, 2025 · Filed Nov 4, 2025
VITL$10.01-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
| 39-Weeks Ended | ||
|---|---|---|
| September 28,2025 | September 29,2024 | |
| Cash flows from operating activities: | ||
| Net income | $49,958 | $42,808 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 9,963 | 9,829 |
| Reduction in the carrying amount of right-of-use assets | 6,018 | 2,793 |
| Amortization and accretion of available-for-sale debt securities | (720) | 96 |
| Amortization of debt issuance costs | 64 | 39 |
| Stock-based compensation expense | 9,126 | 7,572 |
| Deferred taxes | 28 | (267) |
| Uncertain tax positions | 1,580 | — |
| Net realized losses on derivative instruments | 1,325 | 394 |
| Other | 3,878 | 926 |
| Net change in operating assets and liabilities | (53,285) | (14,147) |
| Net cash provided by operating activities | $27,935 | $50,043 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (44,024) | (10,482) |
| Purchases and settlements of derivative instruments | (551) | (669) |
| Purchases of available-for-sale securities | (70,431) | — |
| Maturities and call redemptions of available-for-sale debt securities | 29,240 | 19,505 |
| Proceeds from the sale of available-for-sale debt securities | 404 | — |
| Proceeds from the sale of property, plant and equipment | 1,026 | 1 |
| Net cash (used in) provided by investing activities | $(84,336) | $8,355 |
| Cash flows from financing activities: | ||
| Proceeds from exercise of stock options | 5,512 | 11,305 |
| Proceeds from issuance of common stock under employee stock purchase plan | 379 | 178 |
| Payment of tax withholding obligation on vested restricted stock unit shares | (3,095) | (1,493) |
| Principal payments under finance lease obligations | (3,200) | (2,589) |
| Payment of financing costs | — | (414) |
| Net cash (used in) provided by financing activities | $(404) | $6,987 |
| Net (decrease) increase in cash and cash equivalents | (56,805) | 65,385 |
| Cash and cash equivalents at beginning of the period | 150,601 | 84,149 |
| Cash and cash equivalents at end of the period | $93,796 | $149,534 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $601 | $732 |
| Cash paid for income taxes | 17,230 | 12,873 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Purchases of property, plant and equipment included in accounts payable and accrued liabilities | $4,671 | $433 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.